RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma Group

Autologous stem cell transplantation (ASCT) combined with novel agents is the standard treatment for transplant-eligible, newly diagnosed myeloma (NDMM) patients. Lenalidomide is approved for maintenance after ASCT until progression, although the optimal duration of maintenance is unknown. In this t...

Descripción completa

Detalles Bibliográficos
Autores principales: Luoma, Sini, Anttila, Pekka, Säily, Marjaana, Lundan, Tuija, Heiskanen, Jouni, Siitonen, Timo, Kakko, Sakari, Putkonen, Mervi, Ollikainen, Hanna, Terävä, Venla, Sankelo, Marja, Partanen, Anu, Launonen, Kirsi, Räsänen, Anu, Sikiö, Anu, Suominen, Merja, Bazia, Piotr, Kananen, Kristiina, Lievonen, Juha, Selander, Tuomas, Pelliniemi, Tarja-Terttu, Ilveskero, Sorella, Huotari, Virva, Mäntymaa, Pentti, Tienhaara, Anri, Jantunen, Esa, Silvennoinen, Raija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900265/
https://www.ncbi.nlm.nih.gov/pubmed/31673775
http://dx.doi.org/10.1007/s00277-019-03815-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900265/
https://www.ncbi.nlm.nih.gov/pubmed/31673775
http://dx.doi.org/10.1007/s00277-019-03815-7

Ejemplares similares